The role of HDAC 2 in pressure overload-induced cardiac hypertrophy of rat
Yin Lu
Abstract
Yin Lu
Abstract
Objective To investigate the expression and the role of HDAC2 in the rat model of pressure overload -induced cardiac hypertrophy and the effect of valproic acid sodium on the expression of HDAC2 and the development of cardiac hypertrophy. Methods Male Wistar rats were divided randomly into sham-operated group,cardiac hypertrophy group and valproic acid sodium treatment group. All animals were sacrificed at 14 days and 28 days respectively. The heart/body weight ratio ,myocardium HE stain and the mRNA expression of β-MHC were observed. The expression of HDAC2 was examined by using RT-PCR and immunohistochemistry. Results The heart/body weight ratio and the level of β-MHC mRNA of treatment group decreased compared with cardiac hypertrophy groups; myocardium HE stain showed that the extent of myocardial injury in cardiac hypertrophy group was more serious than that in the treatment groups; The number of positive nucleus in per high power field of treamtment groups for 14 days and 28 days decreased by 34.18% and 36.24% respectively compared with those of cardiac hypertrophy groups, P 0.05. Conclusions The expression of HDAC2 may play an important role in cardiac hypertrophy. Valproic acid sodium may inhibit the expression of HDAC2 and the development of cardiac hypertrophy.[
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the expression and the role of HDAC2 in the rat model of pressure overload -induced cardiac hypertrophy and the effect of valproic acid sodium on the expression of HDAC2 and the development of cardiac hypertrophy. Methods Male Wistar rats were divided randomly into sham-operated group,cardiac hypertrophy group and valproic acid sodium treatment group. All animals were sacrificed at 14 days and 28 days respectively. The heart/body weight ratio ,myocardium HE stain and the mRNA expression of β-MHC were observed. The expression of HDAC2 was examined by using RT-PCR and immunohistochemistry. Results The heart/body weight ratio and the level of β-MHC mRNA of treatment group decreased compared with cardiac hypertrophy groups; myocardium HE stain showed that the extent of myocardial injury in cardiac hypertrophy group was more serious than that in the treatment groups; The number of positive nucleus in per high power field of treamtment groups for 14 days and 28 days decreased by 34.18% and 36.24% respectively compared with those of cardiac hypertrophy groups, P 0.05. Conclusions The expression of HDAC2 may play an important role in cardiac hypertrophy. Valproic acid sodium may inhibit the expression of HDAC2 and the development of cardiac hypertrophy.[
Key concepts: Internal medicine, Muscle hypertrophy, Histone deacetylase 2, Endocrinology, Valproic Acid, Medicine, Cardiac muscle, Immunohistochemistry